Your browser doesn't support javascript.
loading
Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review.
Franco, Julia; de Souza, Rafael N; Lima, Tácio de M; Moriel, Patricia; Visacri, Marília B.
Afiliação
  • Franco J; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
  • de Souza RN; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
  • Lima TM; Department of Pharmaceutical Sciences, 67825Federal Rural University of Rio de Janeiro, Seropédica, RJ, Brazil.
  • Moriel P; Faculty of Pharmaceutical Sciences, University of Campinas, Campinas, SP, Brazil.
  • Visacri MB; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
J Oncol Pharm Pract ; 28(3): 664-685, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35019805
OBJECTIVE: We conducted this scoping review to map and summarize scientific evidence on the role of clinical pharmacists in the palliative care of adults and elderly patients with cancer. DATA SOURCES: A literature search was performed in MEDLINE, PubMed Central, Embase, Web of Science, Scopus, and BVS/BIREME for studies published until November 22nd, 2020. Studies that reported work experiences adopted by clinical pharmacists in the palliative care of adults and elderly patients with cancer were included. Two independent authors performed study selection and data extraction. Any disagreements were resolved by discussion with the third and fourth authors. The pharmacist interventions identified in the included studies were described based on key domains in the DEPICT v.2. DATA SUMMARY: A total of 586 records were identified, of which 14 studies fully met the eligibility criteria. Most of them were conducted in the United States of America (n = 5) and Canada (n = 5) and described the workplace of the pharmacist in clinic/ambulatory (n = 10). Clinical pharmacists performed several activities and provided services, highlighting medication review (n = 12), patient and caregivers education (n = 12), medication histories and-or medication reconciliation (n = 6). The pharmacist interventions were mostly conducted for patients/caregivers (n = 13), by one-on-one contact (n = 14), and by face-to-face (n = 13). Pharmacists were responsible mainly for change or suggestion for change in therapy (n = 12) and patient counselling (n = 12). Pharmacist interventions were well accepted by the clinical team. Overall, studies showed that pharmacists, within an interdisciplinary team, had significant impacts on measured outcomes. CONCLUSIONS: In recent years, there have been advances in the role of the pharmacist in palliative care of patients with cancer and there are great opportunities in this field. They play an important role in managing cancer pain and other symptoms, as well as resolving drug related problems. We encourage more research to be carried out to strengthen this field and to benefit patients with advanced cancer with higher quality of life.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacêuticos / Neoplasias Tipo de estudo: Prognostic_studies / Qualitative_research / Systematic_reviews Limite: Adult / Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacêuticos / Neoplasias Tipo de estudo: Prognostic_studies / Qualitative_research / Systematic_reviews Limite: Adult / Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article